Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Recruiting

I'm Interested

Trial ID: NCT01019148

Purpose

Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.

Official Title

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Stanford Investigator(s)

Jean Y. Tang MD PhD
Jean Y. Tang MD PhD

Professor of Dermatology

Anthony Oro, MD, PhD
Anthony Oro, MD, PhD

Eugene and Gloria Bauer Professor

M. Peter Marinkovich, MD
M. Peter Marinkovich, MD

Associate Professor of Dermatology

Paul A. Khavari, MD, PhD
Paul A. Khavari, MD, PhD

Carl J. Herzog Professor of Dermatology in the School of Medicine

Eligibility


Inclusion Criteria:

   - Clinical diagnosis of RDEB by local dermatologist

   - 7 years of age or older

Exclusion Criteria:

-Medical instability limiting ability to travel to Stanford University Medical Center

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Irene Bailey-Healy
650-721-7149